Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis
Lugaresi et al.
Neuropsychiatric Disease and Treatment; June 2013
Multiple sclerosis (MS) is a chronic demyelinating disease of
The following content is accessible for members only, please sign in.
Loading…